Ireland experienced a notable increase in its trade surplus, reaching EUR 17.37 billion in September 2025, up from EUR 11.56 billion in the same month the previous year. This marked the largest surplus since March. The surge was largely driven by a 27.8% rise in exports year-on-year, totaling EUR 28.5 billion. A significant contributor was a 73.6% jump in the export of medical and pharmaceutical products, which represented 65.5% of Ireland's total exports. Exports to the US saw a remarkable 126% increase, amounting to EUR 16.3 billion, with over 90% comprising chemicals and related products, notably medical and pharmaceutical goods. The United States, the Netherlands, and Great Britain continued to be Ireland's primary export markets.
In terms of imports, there was a 3.7% year-on-year increase, reaching EUR 11.13 billion. This rise was primarily fueled by increased purchases of office machinery and automatic data-processing equipment, which grew by 61.5%. These gains somewhat balanced declines in medical and pharmaceutical imports, which fell by 7.7%, and organic chemicals, which decreased by 26.8%. Ireland's leading import partners included the US (16.1%), Great Britain (11.7%), and China (9.9%).
